Alp Ercan

Alp Ercan

Auto-generated profile, based on publicly available information

Alp Ercan

Department of Plastic, Reconstructive and Aesthetic Surgery, Istanbul University-Cerrahpaşa

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2019 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
AEAlp Ercan
Alp Ercan
SBSemih Baghaki
Semih Baghaki
SSSamıl Suleymanov
Samıl Suleymanov
OAOvgu Aydın
Ovgu Aydın
DKDildar Konukoglu
Dildar Konukoglu
OCOguz Cetinkale
Oguz Cetinkale

24 February 2021 in Microsurgery
Verified
Journal Article
Closed access
PDF file
DADicle Aksoyler
Dicle Aksoyler
Luigi LoscoLuigi Losco
Luigi Losco
ABAlberto Bolletta
Alberto Bolletta
AEAlp Ercan
Alp Ercan
SCShih‐Heng Chen
Shih‐Heng Chen
HCHung-Chi Chen
Hung-Chi Chen

11 March 2020 in Journal of Craniofacial Surgery
Verified
Journal Article
Closed access
AEAlp Ercan
Alp Ercan
LELeman Damla Ercan
Leman Damla Ercan
ADAnil Demiroz
Anil Demiroz
Background: Nasolabial flap is a work-horse flap for coverage of many facial units. However, these flaps have limited mobility and these limit their use in many instances. Facial artery with its numerous small cutaneous perforators can be a source for free-style skin flaps that can be islanded and have greater reach, one of which is nasolabial perforatory flap. Methods: The authors present a case series of 35 patients with central facial unit defects reconstructed by a single flap harvested from the nasolabial sulcus. Results: In our series, we did not encounter any significant flap loss and patient satisfaction was high both functionally and aesthetically. Main drawbacks were temporary venous congestion and hair bearing flaps in male patients. Conclusion: The authors think with its reliability and versatility nasolabial perforator flaps, based on the same donor area as the traditional nasolabial flap can be a valuable addition to our arsenal in reconstruction of central facial unit defects.

26 August 2019 in Aesthetic Plastic Surgery
Verified
Journal Article
Closed access
PDF file
MDMurat Diyarbakirlioglu
Murat Diyarbakirlioglu
AEAlp Ercan
Alp Ercan
YDYunus Dogan
Yunus Dogan

18 September 2021 in Microsurgery
Verified
Journal Article
Closed access
PDF file
DADicle Aksoyler
Dicle Aksoyler
AEAlp Ercan
Alp Ercan
Luigi LoscoLuigi Losco
Luigi Losco
SCShih‐Heng Chen
Shih‐Heng Chen
HCHung-Chi Chen
Hung-Chi Chen

24 September 2020 in Journal of Reconstructive Microsurgery
Verified
Journal Article
Closed access
PDF file
ADAnıl Demiröz
Anıl Demiröz
HDHandan Derebaşınlıoğlu
Handan Derebaşınlıoğlu
AEAlp Ercan
Alp Ercan
HAHakan Arslan
Hakan Arslan
ÖAÖvgü Aydın
Övgü Aydın
YAYağmur Aydın
Yağmur Aydın
Background Ischemia-reperfusion injury plays an important role in flap failure. Ischemic preconditioning technique is the only proven method for preventing ischemia-reperfusion injury, but it is not used widely in daily practice because of difficulties such as prolonging the operation time, need for surgical experience, and increasing the risk of complications. This study has been performed with the assumption that piracetam may be a simple and inexpensive alternative to the preconditioning technique due to its antioxidant, antiaggregant, rheological, anti-inflammatory, antiapoptotic, cytoprotective, and immune modulating effects.Methods Thirty-two rats were divided into four groups and latissimus dorsi musculocutaneous flaps were raised. No extra procedure was applied, and no treatment was given to the control group. Four hours of ischemia was created by clamping the thoracodorsal pedicle in the second group. The animals in the third group were treated with 10 minutes of ischemia and reperfusion periods as a preconditioning procedure before the 4 hours of ischemia. Animals in the fourth group received systemic piracetam 30 minutes before and 6 days after reperfusion. Nitric oxide and myeloperoxidase levels in serum and tissue, acute inflammatory cell response, and vascular proliferation in tissue were examined at the postoperative 24th hour and 10th day.Results Myeloperoxidase activity in both preconditioning and piracetam groups, was significantly lower than the ischemia-reperfusion group. Acute inflammatory cell response was similarly decreased in both preconditioning and piracetam groups compared with ischemia-reperfusion group. Tissue measurements of nitric oxide were also significantly higher in both preconditioning and piracetam groups than in the ischemia-reperfusion group. However, vascular proliferation increased in the preconditioning group, while it did not show any significant change in the piracetam group.Conclusion This study shows that systemic piracetam treatment provides protection against ischemia-reperfusion injury in musculocutaneous flaps and can offer a simple and inexpensive alternative to the preconditioning technique.